Labiana Health SA
MAD:LAB
Labiana Health SA
Inventory
Labiana Health SA
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Labiana Health SA
MAD:LAB
|
Inventory
€10.7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Almirall SA
MAD:ALM
|
Inventory
€189.4m
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
|
Inventory
€327.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
16%
|
|
|
F
|
Faes Farma SA
MAD:FAE
|
Inventory
€154.7m
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
|
|
Laboratorio Reig Jofre SA
MAD:RJF
|
Inventory
€71.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
Labiana Health SA
Glance View
Labiana Health SA manufactures sterile and lyophilized dosage forms. The company is headquartered in Pozuelo De Alarcon, Madrid and currently employs 477 full-time employees. The company went IPO on 2022-06-24. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.
See Also
What is Labiana Health SA's Inventory?
Inventory
10.7m
EUR
Based on the financial report for Dec 31, 2024, Labiana Health SA's Inventory amounts to 10.7m EUR.
What is Labiana Health SA's Inventory growth rate?
Inventory CAGR 5Y
-5%
Over the last year, the Inventory growth was -14%. The average annual Inventory growth rates for Labiana Health SA have been -8% over the past three years , -5% over the past five years .
